Argent Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
2,352
+70
| +3% | +$13K | 0.13% | 112 |
|
|
2025
Q1 | $478K | Buy |
2,282
+78
| +4% | +$16.3K | 0.16% | 107 |
|
|
2024
Q4 | $392K | Sell |
2,204
-127
| -5% | -$22.6K | 0.15% | 103 |
|
|
2024
Q3 | $460K | Sell |
2,331
-149
| -6% | -$29.4K | 0.17% | 104 |
|
|
2024
Q2 | $425K | Sell |
2,480
-344
| -12% | -$59K | 0.17% | 101 |
|
|
2024
Q1 | $514K | Sell |
2,824
-876
| -24% | -$160K | 0.2% | 93 |
|
|
2023
Q4 | $573K | Sell |
3,700
-143
| -4% | -$22.2K | 0.25% | 87 |
|
|
2023
Q3 | $573K | Sell |
3,843
-189
| -5% | -$28.2K | 0.26% | 84 |
|
|
2023
Q2 | $543K | Sell |
4,032
-351
| -8% | -$47.3K | 0.25% | 83 |
|
|
2023
Q1 | $699K | Buy |
4,383
+135
| +3% | +$21.5K | 0.33% | 71 |
|
|
2022
Q4 | $687K | Buy |
4,248
+65
| +2% | +$10.5K | 0.36% | 68 |
|
|
2022
Q3 | $561K | Buy |
4,183
+189
| +5% | +$25.3K | 0.33% | 72 |
|
|
2022
Q2 | $612K | Sell |
3,994
-453
| -10% | -$69.4K | 0.34% | 74 |
|
|
2022
Q1 | $721K | Buy |
4,447
+374
| +9% | +$60.6K | 0.39% | 73 |
|
|
2021
Q4 | $551K | Buy |
4,073
+2,017
| +98% | +$273K | 0.3% | 81 |
|
|
2021
Q3 | $222K | Buy |
2,056
+25
| +1% | +$2.7K | 0.13% | 126 |
|
|
2021
Q2 | $229K | Buy |
2,031
+35
| +2% | +$3.95K | 0.14% | 123 |
|
|
2021
Q1 | $216K | Sell |
1,996
-2,591
| -56% | -$280K | 0.14% | 126 |
|
|
2020
Q4 | $491K | Buy |
4,587
+350
| +8% | +$37.5K | 0.3% | 89 |
|
|
2020
Q3 | $371K | Hold |
4,237
| – | – | 0.25% | 97 |
|
|
2020
Q2 | $415K | Buy |
4,237
+1,426
| +51% | +$140K | 0.32% | 88 |
|
|
2020
Q1 | $214K | Hold |
2,811
| – | – | 0.21% | 108 |
|
|
2019
Q4 | $248K | Buy |
+2,811
| New | +$248K | 0.19% | 96 |
|